6.6(top 2%)
Impact Factor
7.3(top 2%)
extended IF
143(top 2%)
H-Index
5.6K
authors
9.8K
papers
241.1K
citations
5.8K
citing journals
74.4K
citing authors

Most Cited Articles of Haematologica

TitleYearCitations
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine2004697
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study2006590
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients2007573
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials2006510
European consensus on grading bone marrow fibrosis and assessment of cellularity2005476
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype2005419
Lactoferrin: a general review1995399
Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential2003360
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)2006333
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma2008326
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients2017323
Liver iron concentrations and urinary hepcidin in beta-thalassemia2007300
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype2009299
Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta12011297
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A2009294
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction2007286
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-12009272
Survival for older patients with acute myeloid leukemia: a population-based study2012270
Mesenchymal stem cells: the fibroblasts' new clothes?2009269
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice2007269
Platelet receptors and signaling in the dynamics of thrombus formation2009268
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)2007268
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies2013267
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases2010267
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments2008259